Lower prices for 15 drugs, including Ozempic and Wegovy, are expected to be announced by the end of the month. The price ...

Eli Lilly and Novo Nordisk agreed to discount their GLP-1 medications from $1350 per month to around $245 to $350 per month.

Mounjaro menus’ are lifesavers for people like me - IN FOCUS: There’s a reason why millions of people in the UK are on weight ...

This article was reviewed by Darragh O’Carroll, MD. Semaglutide Side Effects: What to Know Key takeaways: Common semaglutide ...

After writing dozens of GLP-1 articles over the past year, one issue that consistently comes up is the affordability of ...

As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...

Drugmaker Eli Lilly said it would soon start late-stage trials for eloralintide, a drug mimicking the pancreatic hormone amylin that slows digestion and reduces hunger.

Below, doctors explain everything you need to know about the phenomenon. It’s important to be clear upfront that “Ozempic ...

New versions of drugs like Wegovy, Ozempic, Mounjaro and Zepbound, including pills, will be easier to take, more effective ...

Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war ...

The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker ...